Evidence map›Paper›PMID 42737854›Full record

SynthesisInternational journal of molecular sciences2026

Cognitive and Behavioural Profile of SOD1-ALS Across the ALS-FTD Spectrum: A Systematic Review.

Francesco Ginanni, Francesco Nicoletti, Caterina Meoni, Lucrezia Becattini, Michelangelo Mancuso, Cecilia Carlesi, Francesca Bianchi

Abstract readSystematic Review
PubMed Full text at PMC Publisher
In one paragraph

Synthesis in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Francesco GinanniDepartment of Clinical and Experimental Medicine, Neurological Institute, University of Pisa, 56126 Pisa, Italy.
Francesco NicolettiDepartment of Clinical and Experimental Medicine, Neurological Institute, University of Pisa, 56126 Pisa, Italy.
Caterina MeoniDepartment of Clinical and Experimental Medicine, Neurological Institute, University of Pisa, 56126 Pisa, Italy.
Lucrezia BecattiniDepartment of Clinical and Experimental Medicine, Neurological Institute, University of Pisa, 56126 Pisa, Italy.
Michelangelo MancusoDepartment of Clinical and Experimental Medicine, Neurological Institute, University of Pisa, 56126 Pisa, Italy.ORCID 0000-0003-2738-8562
Cecilia CarlesiNeurology Unit, Azienda Ospedaliero Universitaria Pisana, 56126 Pisa, Italy.
Francesca BianchiNeurology Unit, Azienda Ospedaliero Universitaria Pisana, 56126 Pisa, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Amyotrophic Lateral Sclerosis (ALS) is increasingly recognized as a multisystem disorder. However,

Indexed as

Amyotrophic Lateral SclerosisCognitionFrontotemporal DementiaSuperoxide Dismutase-1HumansMutationSOD1 protein, humanSuperoxide Dismutase-1amyotrophic lateral sclerosis (ALS)behavioural impairmentcognitive impairmentfrontotemporal dementia (FTD)neuropsychologySOD1systematic review

Identifiers

PMID42737854
PMCPMC13565861

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.